Why Is Processa Pharmaceuticals (PCSA) Stock Up 29% Today?
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Processa Pharmaceuticals stock is up on Tuesday as PCSA investors react to approval for a Phase 2 clinical trial of NGC-Cap.
The post Why Is Processa Pharmaceuticals (PCSA) Stock Up 29% Today? appeared first on InvestorPlace.
More From InvestorPlace